FI924850L - N-(a-substituerad pyridinyl)karbonyldipeptider antihypertensiva aemnen - Google Patents
N-(a-substituerad pyridinyl)karbonyldipeptider antihypertensiva aemnen Download PDFInfo
- Publication number
- FI924850L FI924850L FI924850A FI924850A FI924850L FI 924850 L FI924850 L FI 924850L FI 924850 A FI924850 A FI 924850A FI 924850 A FI924850 A FI 924850A FI 924850 L FI924850 L FI 924850L
- Authority
- FI
- Finland
- Prior art keywords
- substituerad
- aemnen
- dipeptide
- antihypertensive
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91102950A EP0500989B1 (en) | 1991-02-27 | 1991-02-27 | N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| PCT/EP1992/000400 WO1992015608A1 (en) | 1991-02-27 | 1992-02-26 | N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI924850A7 FI924850A7 (fi) | 1992-10-26 |
| FI924850A0 FI924850A0 (fi) | 1992-10-26 |
| FI924850L true FI924850L (fi) | 1992-10-26 |
Family
ID=8206465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924850A FI924850L (fi) | 1991-02-27 | 1992-02-26 | N-(a-substituerad pyridinyl)karbonyldipeptider antihypertensiva aemnen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5432159A (cs) |
| EP (1) | EP0500989B1 (cs) |
| JP (1) | JPH05507295A (cs) |
| AT (1) | ATE174343T1 (cs) |
| AU (1) | AU650954B2 (cs) |
| BR (1) | BR9204779A (cs) |
| CA (1) | CA2081471A1 (cs) |
| CZ (1) | CZ280952B6 (cs) |
| DE (1) | DE69130605T2 (cs) |
| ES (1) | ES2037613B1 (cs) |
| FI (1) | FI924850L (cs) |
| HU (1) | HUT62313A (cs) |
| NO (1) | NO924076L (cs) |
| PL (1) | PL167915B1 (cs) |
| PT (1) | PT100148B (cs) |
| RO (1) | RO111369B1 (cs) |
| RU (1) | RU2098424C1 (cs) |
| WO (1) | WO1992015608A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5825094A (en) * | 1993-11-19 | 1995-06-06 | Astra Aktiebolag | Novel dipeptide derivatives |
| JP2000510481A (ja) * | 1997-04-04 | 2000-08-15 | ファイザー・プロダクツ・インク | ニコチンアミド誘導体 |
| IL136271A (en) * | 1998-09-22 | 2005-06-19 | Kaneka Corp | Process for the preparation of n<2>-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline |
| HUP0400637A2 (hu) | 2001-01-31 | 2004-06-28 | Pfizer Products Inc. | Nikotinamid-biaril-származékok, amelyek PDE4 izozimek inhibitoraiként alkalmazhatók és ezeket tartalmazó gyógyszerkészítmények |
| US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| PL365443A1 (en) | 2001-01-31 | 2005-01-10 | Pfizer Products Inc. | Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| CA2436544A1 (en) | 2001-01-31 | 2002-08-08 | Pfizer Products Inc. | Ether derivatives useful as inhibitors of pde4 isozymes |
| WO2003033471A1 (fr) * | 2001-10-17 | 2003-04-24 | Tobishi Pharmaceutical Co.,Ltd | Nouveau derive de pyridone et agent therapeutique pour les maladies du systeme circulatoire les contenant |
| BR0307279A (pt) * | 2002-01-29 | 2004-12-28 | Wyeth Corp | Métodos para fechar e abrir um semi-canal e uma célula, tecido orgãnico ou órgão, para prevenir ou tratar o estresse de tecido orgãnico ou órgão em um mamìfero, para aumentar a comunicação intracelular da junção com intervalo em uma célula, tecido orgãnico ou órgão, para tratamento de queimaduras, de tromboses, da acidose respitatória e metabólica, e da arritmia focal, para tratar e prevenir o dano de célula e tecido orgãnico resultante de nìveis elevados de glicose no sangue, para tratamento da fibrilação atrial crÈnica e da epilepsia, para criar composto candidatos que modulem a função de semi-canal, para citoproteger tecido orgãnico ou um órgão de um mamìfero em necessidade de tal tratamento, e para prevenir ou tratar o dano da reperfusão em um mamìfero |
| SI21507A (sl) * | 2003-05-16 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo spojin z ace inhibitornim delovanjem |
| WO2006113199A1 (en) * | 2005-04-14 | 2006-10-26 | Merck & Co., Inc. | Vla-4 antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU537592B2 (en) * | 1979-04-02 | 1984-07-05 | E.R. Squibb & Sons, Inc. | Mercaptoacyldipeptides |
| NZ202232A (en) * | 1981-11-06 | 1985-08-16 | Smithkline Beckman Corp | N-carboxyalkylproline-containing tripeptides and pharmaceutical compositions |
| DE3332633A1 (de) * | 1983-09-09 | 1985-04-04 | Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München | Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel |
-
1991
- 1991-02-27 AT AT91102950T patent/ATE174343T1/de not_active IP Right Cessation
- 1991-02-27 EP EP91102950A patent/EP0500989B1/en not_active Expired - Lifetime
- 1991-02-27 DE DE69130605T patent/DE69130605T2/de not_active Expired - Fee Related
- 1991-12-16 ES ES9102792A patent/ES2037613B1/es not_active Expired - Fee Related
-
1992
- 1992-02-21 PT PT100148A patent/PT100148B/pt not_active IP Right Cessation
- 1992-02-26 US US07/938,248 patent/US5432159A/en not_active Expired - Lifetime
- 1992-02-26 JP JP92504931A patent/JPH05507295A/ja active Pending
- 1992-02-26 BR BR9204779A patent/BR9204779A/pt not_active Application Discontinuation
- 1992-02-26 CZ CS923220A patent/CZ280952B6/cs unknown
- 1992-02-26 CA CA002081471A patent/CA2081471A1/en not_active Abandoned
- 1992-02-26 WO PCT/EP1992/000400 patent/WO1992015608A1/en active IP Right Grant
- 1992-02-26 RO RO92-01349A patent/RO111369B1/ro unknown
- 1992-02-26 HU HU9203324A patent/HUT62313A/hu unknown
- 1992-02-26 PL PL92296625A patent/PL167915B1/pl unknown
- 1992-02-26 RU RU9292016314A patent/RU2098424C1/ru active
- 1992-02-26 AU AU12783/92A patent/AU650954B2/en not_active Ceased
- 1992-02-26 FI FI924850A patent/FI924850L/fi unknown
- 1992-10-21 NO NO92924076A patent/NO924076L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2081471A1 (en) | 1992-08-28 |
| RU2098424C1 (ru) | 1997-12-10 |
| ATE174343T1 (de) | 1998-12-15 |
| DE69130605T2 (de) | 1999-05-20 |
| WO1992015608A1 (en) | 1992-09-17 |
| PL296625A1 (en) | 1993-08-09 |
| RO111369B1 (ro) | 1996-09-30 |
| NO924076L (no) | 1992-12-21 |
| JPH05507295A (ja) | 1993-10-21 |
| US5432159A (en) | 1995-07-11 |
| HUT62313A (en) | 1993-04-28 |
| PL167915B1 (pl) | 1995-12-30 |
| FI924850A7 (fi) | 1992-10-26 |
| HU9203324D0 (en) | 1993-01-28 |
| FI924850A0 (fi) | 1992-10-26 |
| CZ280952B6 (cs) | 1996-05-15 |
| BR9204779A (pt) | 1993-08-17 |
| AU650954B2 (en) | 1994-07-07 |
| CZ322092A3 (en) | 1993-02-17 |
| ES2037613A1 (es) | 1993-06-16 |
| PT100148A (pt) | 1993-05-31 |
| EP0500989B1 (en) | 1998-12-09 |
| PT100148B (pt) | 1999-06-30 |
| AU1278392A (en) | 1992-10-06 |
| NO924076D0 (no) | 1992-10-21 |
| ES2037613B1 (es) | 1994-03-16 |
| EP0500989A1 (en) | 1992-09-02 |
| DE69130605D1 (de) | 1999-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941398A7 (fi) | Modifioituja peptidijohdannaisia | |
| DE69210904D1 (de) | Wiedergabeanordnung | |
| DE69218637D1 (de) | Wiedergabeanordnung | |
| FI923494A7 (fi) | Peptidyylijohdannaisia | |
| FI921884A7 (fi) | Fosfono/biarylsubstituerade dipeptidderivat | |
| DE69325616D1 (de) | Wiedergabegerät | |
| NO952865D0 (no) | 6-leddede nitrogenholdige heteroaryl-oksazolidinoner | |
| NO921451D0 (no) | Heterocykliske amider | |
| DE69224409D1 (de) | Verstärkerschaltung | |
| DE69320997D1 (de) | Wiedergabegerät | |
| FI945416L (fi) | Dolastatiinijohdannaisia | |
| FI94203B (fi) | Kaiutin | |
| FI924850L (fi) | N-(a-substituerad pyridinyl)karbonyldipeptider antihypertensiva aemnen | |
| DE69323107D1 (de) | Wiedergabegerät | |
| DE69210751D1 (de) | Aufzeichnungsgerät | |
| DE69223427D1 (de) | Leseverstärkerschaltung | |
| DE69224125D1 (de) | Leseverstärker | |
| FI950486A0 (fi) | Amidijohdannaiset | |
| FI925693A7 (fi) | Sulfonimidamider | |
| DE69219254D1 (de) | Audioverstärker | |
| DE69215912D1 (de) | Geschalteter Brückenverstärker | |
| DE59208486D1 (de) | Verstärker | |
| FI923797A7 (fi) | N-substituoidut aminometaanidifosfonihapot | |
| DE69230126D1 (de) | Wiedergabegerät | |
| DE69215995D1 (de) | Verstärkerschaltung |